Mumbai: The Maharashtra Food and Drug Administration has taken strict action against Johnson&Johnson Private Limited. According to the news, the Maharashtra FDA has cancelled the manufacturing license of Johnson&Johnson Private Limited's Johnson Baby Powder located in Mulund, Mumbai. In fact, powder samples were taken in Pune and Nashik, which did not meet the standards. After this, this decision has been taken.

It has been told by the Maharashtra FDA that the samples collected are not in line with the scale in terms of quality. Which is also not good in terms of children's skin. Therefore, the state government body has issued a show cause notice to the company under the Drugs and Cosmetics Act 1940. The Maharashtra FDA has also issued instructions to the company to withdraw the stock of baby powder from the market.

The state government body also said that the use of the product can affect the skin health of newborns. According to a report received, last month Johnson&Johnson said that it will stop selling baby powder globally in 2023. It was also told that after more than 2 years, the sale of a product in America stopped. In 2020, J&J announced that it would stop selling its talcum baby powder in the US and Canada. Because there was a huge decline in demand after "misinformation" about the safety of the product amid legal challenges.

Bharat Jodo Yatra 10th Day Updates: Yatra enters Puthiyakavu

No 'pollution' from stubble in UP.., Yogi govt made masterplan for farmers

'Modi Ji is better than most Sikhs like us..,' Iqbal Singh lists PM's work